Obstetrics & Gynecology, Female Pelvic Medicine and Reconstructive Surgery · Milford, MA
NPI
1841498755
Since 2007
Specialty
Obstetrics & Gynecology, Female Pelvic Medicine and Reconstructive Surgery
Code 207VF0040X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
115 Water St
Milford, MA, 01757
Phone (774) 462-3380
Groups this clinician bills Medicare through
Medicare paid, 2024
$93K
4,709 services
Medicare patients, 2024
220
Average age 73
Drug cost, 2024
$367K
1,631 prescriptions
Company payments, 2025
$2,235
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amos O Adelowo was code J0585 (injection, onabotulinumtoxina, 1 unit), 2,800 times for 19 patients. In total Amos O Adelowo billed 4,709 services in 51 codes, and Medicare paid $93K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 2,800 | 19 | $4.93 | $14K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 825 | 13 | $0.23 | $189 |
| 51798 Ultrasound - Nonspecific | Office | 209 | 156 | $8.52 | $1,781 |
| 81003 Clinical Chemistry | Office | 151 | 119 | $2.20 | $332 |
| 99214 Office E&M - Established | Office | 127 | 94 | $92.13 | $12K |
| 99213 Office E&M - Established | Office | 120 | 89 | $65.70 | $7,884 |
| 99204 Office E&M - New | Office | 60 | 60 | $117.60 | $7,056 |
| 81002 Clinical Chemistry | Office | 42 | 29 | $3.41 | $143 |
| 51700 Other Organ Systems | Office | 38 | 14 | $58.31 | $2,216 |
| 52000 Cystourethroscopy | Office | 36 | 35 | $150.74 | $5,427 |
| 51741 Test - Miscellaneous | Office | 22 | 22 | $5.48 | $120 |
| 57150 Other Organ Systems | Office | 22 | 13 | $44.82 | $986 |
| 52287 Cystourethroscopy | Office | 22 | 19 | $314.77 | $6,925 |
| 51729 Other Organ Systems | Office | 21 | 21 | $294.96 | $6,194 |
| 51784 Neurologic | Office | 21 | 21 | $24.69 | $519 |
By year: 2022 $92K for 3,184 services; 2023 $99K for 3,414 services; 2024 $93K for 4,709 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 151 | 119 | $2.20 | $332 |
| 81002 Clinical Chemistry | 42 | 29 | $3.41 | $143 |
Medicare prescription drug claims, 2024
In 2024, the drug Amos O Adelowo prescribed most often to Medicare patients was Myrbetriq (Mirabegron), with 270 prescriptions and refills. In total Amos O Adelowo wrote 1,631 Medicare prescriptions that cost $367K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Myrbetriq Mirabegron | 270 | 426 | 78 | $187K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 197 | 197 | 124 | $1,794 |
| Trospium Chloride Er Trospium Chloride | 162 | 323 | 65 | $33K |
| Estradiol Generic | 101 | 215 | 72 | $6,660 |
| Methenamine Hippurate Generic | 96 | 123 | 21 | $5,849 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 90 | 90 | 71 | $245 |
| Gemtesa Vibegron | 82 | 140 | 32 | $67K |
| Trospium Chloride Generic | 72 | 146 | 29 | $4,316 |
| Darifenacin Er Darifenacin Hydrobromide | 67 | 120 | 31 | $8,746 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 67 | 174 | 26 | $1,698 |
| Fosfomycin Tromethamine Generic | 50 | 70 | 21 | $10K |
| Solifenacin Succinate Generic | 43 | 109 | 21 | $1,383 |
| Mirabegron Er Mirabegron | 43 | 59 | 16 | $21K |
| Halobetasol Propionate Generic | 43 | 47 | 23 | $1,875 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 36 | 36 | 31 | $156 |
Brand drugs: - claims; generic drugs: 1,197 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amos O Adelowo $2,235 ($2,235 in general payments such as food, travel and fees) from 6 companies. The largest payer was Medtronic, Inc. with $1,462.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.